An Overview of Cognitive Disturbances in Multiple Sclerosis, Progression and Management

Raed Almalki

Authors

Raed Almalki

Keywords:

Abstract

This review will concentrate on discovery of cognitive disability in MS and available treatment options to decrease symptoms. We performed a search using electronic databases; MEDLINE, and EMBASE, through October, 2019. Search strategies used following MeSH terms in searching: "Multiple Sclerosis", "Cognitive", "screening", "management". Cognitive dysfunctions are constant signs and symptoms of multiple sclerosis (MS) and occur in up to 65% of individuals. Especially memory, attention, executive and visual constructive functions suffer. These problems strongly impact individuals' capacity to work, social relationships, and quality of life. Signs and symptoms of physical disabilities can occur separately. Cognitive disorders are clear indicators of MS progression, since they stand for highly complicated features that depend on the integrity of the neuronal networks. Yet, severe dementia is relatively uncommon.

Downloads

How to Cite

An Overview of Cognitive Disturbances in Multiple Sclerosis, Progression and Management. (2020). Global Journal of Medical Research, 20(F3), 39-44. https://medicalresearchjournal.org/index.php/GJMR/article/view/1972

Download Citation

References

Maria Amato, Valentina Zipoli, Emilio Portaccio (2006) Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies. 245(1-2), 41-46.

Maria Amato, G Ponziani, G Pracucci, L Bracco, G Siracusa, L Amaducci (1995) Cognitive Impairment in Early-Onset Multiple Sclerosis. 52(2), 168.

L Feuillet, F Reuter, B Audoin, I Malikova, K Barrau, A Cherif, J Pelletier (2007) Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis. 13(1), 124-127.

M Amato, G Ponziani, G Siracusa, S Sorbi (2001) Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. 58, 1602-1606.

Anat Achiron, Joab Chapman, David Magalashvili, Mark Dolev, Mor Lavie, Eran Bercovich, Michael Polliack, Glen Doniger, Yael Stern, Olga Khilkevich, Shay Menascu, Gil Hararai, Micharel Gurevich, Yoram Barak (2013) Modeling of Cognitive Impairment by Disease Duration in Multiple Sclerosis: A Cross-Sectional Study. 8(8), e71058.

M Amato, L Krupp, L Charvet (2016) Pediatric multiple sclerosis: Cognition and mood. 87, 82-S87.

A Labiano-Fontcuberta, M Martínez-Ginés, Y Aladro (2016) A comparison study of cognitive deficits in radiologically and clinically isolated syndromes. 22, 250-253.

B Glanz, C Holland, S Gauthier, E Amunwa, Z Liptak, M Houtchens, R Sperling, S Khoury, Crg Guttmann, H Weiner (2007) Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis. 13(8), 1004-1010.

Marianna Cortese, Trond Riise, Kjetil Bjørnevik, Alok Bhan, Elisabeth Farbu, Nina Grytten, Ineke Hogenesch, Rune Midgard, Cecilia Smith Simonsen, Wenche Telstad, Alberto Ascherio, Kjell‐morten Myhr (2016) Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom. 80(4), 616-624.

Maria Amato, Lorenzo Razzolini, Benedetta Goretti, Maria Stromillo, Francesca Rossi, Antonio Giorgio, Bahia Hakiki, Marta Giannini, Luisa Pastò, Emilio Portaccio, Nicola De Stefano (2013) Cognitive reserve and cortical atrophy in multiple sclerosis. 80(19), 1728-1733.

G Bergendal, S Fredrikson, O Almkvist (2007) Selective Decline in Information Processing in Subgroups of Multiple Sclerosis: An 8-Year Longitudinal Study. 57(4), 193-202.

Maria Amato, Benedetta Goretti, Angelo Ghezzi, Bahia Hakiki, Claudia Niccolai, Silvia Lori, Lucia Moiola, Monica Falautano, Rosa Viterbo, Francesco Patti, Sabina Cilia, Carlo Pozzilli, Valentina Bianchi, Marco Roscio, Vittorio Martinelli, Giancarlo Comi, Emilio Portaccio, Maria Trojano (2014) Neuropsychological features in childhood and juvenile multiple sclerosis. 83(16), 1432-1438.

Msa Deloire, A Ruet, D Hamel (2011) MRI predictors of cognitive outcome in early multiple sclerosis. 76, 1161-1167.

Luis Ruano, Emilio Portaccio, Benedetta Goretti, Claudia Niccolai, Milton Severo, Francesco Patti, Sabina Cilia, Paolo Gallo, Paola Grossi, Angelo Ghezzi, Marco Roscio, Flavia Mattioli, Chiara Stampatori, Maria Trojano, Rosa Viterbo, Maria Amato (2017) Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. 23(9), 1258-1267.

Macías Islas, M Ciampi, E (2019) Assessment and Impact of Cognitive Impairment in Multiple Sclerosis: An Overview. 7(1), 22.

S Rao, G Leo, L Bernardin, F Unverzagt (1991) Cognitive dysfunction in multiple sclerosis. 1. Frequency, patterns, and prediction. 41, 685-691.

Stephen Rao, Jordan Grafman, Diane Digiulio, Wiley Mittenberg, Linda Bernardin, Gary Leo, Tracy Luchetta, Frederick Unverzagt (1993) Memory dysfunction in multiple sclerosis: Its relation to working memory, semantic encoding, and implicit learning.. 7(3), 364-374.

Nancy Chiaravalloti, John Deluca (2008) Cognitive impairment in multiple sclerosis. 7(12), 1139-1151.

Catherine Archibald, John Fisk (2000) Information Processing Efficiency in Patients with Multiple Sclerosis. 22(5), 686-701.

Katharina Nebel, Holger Wiese, Julia Seyfarth, Elke Gizewski, Philipp Stude, Hans-Christoph Diener, Volker Limmroth (2007) Activity of attention related structures in multiple sclerosis patients. 1151, 150-160.

Y Barak, A Achiron (2002) Effect of Interferon-beta-1b on cognitive functions in multiple sclerosis. 47, 11-14.

Claudia Engel, Brigitte Greim, Uwe Zettl (2007) Diagnostics of cognitive dysfunctions in multiple sclerosis. 254(S2), II30-II34.

X Montalban, J Rio (2006) Interferons and cognition. 245(1-2), 137-140.

T Patzold, M Schwengelbeck, L-M Ossege, J-P Malin, E Sindern (2002) Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis. 105(3), 164-168.

I Uttner, S Müller, C Zinser, M Maier, S Süßmuth, A Claus, B Ostermann, E Elitok, D Ecker, J Brettschneider, R Gold, H Tumani (2005) Reversible impaired memory induced by pulsed methylprednisolone in patients with MS. 64(11), 1971-1973.

H Zéphir, J Dujardin, K (2005) Oneyear cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis. 11, 360-363.

A Goodman, T Brown, K Edwards (2010) A phase 3 trial of extended release oral dalfampridine in multiple sclerosis. 68, 494-502.

Yael Goverover, Nancy Chiaravalloti, Amanda O'brien, John Deluca (2018) Evidenced-Based Cognitive Rehabilitation for Persons With Multiple Sclerosis: An Updated Review of the Literature From 2007 to 2016. 99(2), 390-407.

Kim Meijer, Anand Eijlers, Linda Douw, Bernard Uitdehaag, Frederik Barkhof, Jeroen Geurts, Menno Schoonheim (2017) Increased connectivity of hub networks and cognitive impairment in multiple sclerosis. 88(22), 2107-2114.

J Haselkorn, C Hughes, Rae Grant, A (2015) Summary of comprehensive systematic review: Rehabilitation in multiple sclerosis [RETIRED]. 85(21), 1896-1903.

Nancy Chiaravalloti, John Deluca, Nancy Moore, Joseph Ricker (2005) Treating learning impairments improves memory performance in multiple sclerosis: a randomized clinical trial. 11(1), 58-68.